# Maximus, Inc.: Form 10-Q for the period ended Dec 31, 2021

- Company: [Maximus, Inc.](/companies/mms.md) (CIK 1032220)
- Form: 10-Q
- Filed: 2022-02-03
- Accepted by EDGAR: Feb 3, 2022, 19:51 ET
- Period: 2021-12-31
- Accession: 0001628280-22-001760
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1032220/000162828022001760/mms-20211231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1032220/000162828022001760/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-10-01 to 2021-12-31 | $1.15bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-10-01 to 2021-12-31 | $922.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2021-10-01 to 2021-12-31 | $228.2m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2021-10-01 to 2021-12-31 | $124.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-10-01 to 2021-12-31 | $81.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2021-10-01 to 2021-12-31 | $18.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-10-01 to 2021-12-31 | $53.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-10-01 to 2021-12-31 | $0.85 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-10-01 to 2021-12-31 | $0.86 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-10-01 to 2021-12-31 | 62,445,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-10-01 to 2021-12-31 | −$2.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-10-01 to 2021-12-31 | $6.3m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 3 months, 2021-10-01 to 2021-12-31 | $1.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-12-31 | $181.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $1.15bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $4.18bn | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $710.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-12-31 | $2.65bn | us-gaap:Liabilities |
| Long-term debt | at 2021-12-31 | $1.52bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-12-31 | $78.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-12-31 | $1.53bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 33,215 characters.

*The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with "Risk Factors," "Forward-Looking Statements," and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2021 filed with the Securities and Exchange Commission on November 18, 2021 (the "2021 Form 10-K") and elsewhere in this Quarterly Report on Form 10-Q, as applicable.*

### Business Overview

We are a leading operator of government health and human services programs worldwide. We are a responsible and reliable contracting partner to governments under our mission of *Helping Government Serve the People®*. Governments rely on our financial stability and proven expertise in helping people connect and use critical government programs. We use our experience, business process management expertise, innovation, and technology solutions to help government agencies run effective, efficient, and accountable programs.

Our primary portfolio of work is tied to business process services ("BPS") in the health services and human services markets. Our growth over the last decade was driven by new work, such as that from the Affordable Care Act ("ACA") in the United States ("U.S."), an evolving digital transformation to meet the modernization needs of our clients, and growing demand for independent and conflict-free clinical services including assessments, appeals, and independent medical reviews in multiple geographies. Our growth has been supplemented by strategic acquisitions.

We experienced both favorable and unfavorable impacts as a result of the Coronavirus ("COVID-19") global pandemic. While some of the programs we support have experienced reduced volumes due to the pandemic, we have also been successful in winning new contracts to meet the immediate needs of our customers, including contract tracing and disease investigation, vaccine information lines, and unemployment insurance administration. Proving the value of our business model, we have converted a number of these relationships into longer-term contract opportunities. The individuals and families served under these programs are those considered some of the most vulnerable to COVID-19. As a result, we believe our operations support programs that are vital for their safety and wellbeing.

We continue to execute upon our three-fold strategy to accelerate our progress and drive the next phase of our growth through:

- Digital transformation. We are using digital technologies to transform the experience of our customers and our employees. We believe that these technologies can help our government clients run their programs in a more streamlined manner and make it easier for individuals to interact with these programs.
- Clinical evolution. We are expanding our clinical-related services and are experienced at delivering clinical BPS at scale. We have established an extensive set of services that frequently requires a network of healthcare professionals who can complete clinical assessments, provide occupational health and independent medical review services, and adjudicate complicated benefits appeals. With the formation of Maximus Public Health ("MPH"), we are able to serve as a resource to governments as they respond to public health threats. These efforts include providing health information and COVID-19 test results and vaccination information through our citizen engagement centers in key states and counties across the nation.
- Market expansion. We continue with our existing strategy to expand our markets by bringing our core capabilities to new programs and clients, adding new capabilities to access adjacent markets, and through geographic expansion. In fiscal year 2021, we expanded our clinical assessments and public health work, and completed two acquisitions in the United States to increase our digital and clinical capabilities, as well as create stronger relationships in key U.S. federal government agencies.

The macro-trends for our business remain unchanged. As the pandemic has underscored, governments around the world need better solutions to deliver on policy priorities that can change rapidly. Social welfare programs that reflect long-term societal commitments and priorities increasingly face rising demand, shifting demographics, and unsustainable program costs. We believe that Maximus is well positioned to address these challenges and be a transformative partner through our scalable, cost-effective, and operationally efficient services for a wide range of government programs.

### Financial Overview

A number of factors have affected our results for the first quarter of fiscal year 2022, the most significant of which we have listed below. More detail on these changes is presented below within our "Results of Operations" section.

- During fiscal year 2021, we acquired VES Group, Inc. ("VES"), the Federal Division of Attain, LLC ("Attain") and Connect Assist Holdings Limited ("Connect Assist"). At the start of fiscal year 2022, we acquired the student loan servicing business from Navient, rebranded as Aidvantage. From the date of each acquisition, we have received the benefit of additional revenue, as well as additional operating costs. In completing these acquisitions, we have allocated a portion of each purchase price to identifiable intangible assets, which we are amortizing over the estimated useful lives of each asset.
- To fund the acquisition of VES, we entered into a new credit facility comprised of fixed term debt and a new revolving credit facility. The cost of servicing this debt, as well as the cost of the debt facilities, has resulted in an increase in our interest expense.
- Our services in fiscal years 2022 and 2021 were affected by the COVID-19 pandemic. We have received the benefit from new, short-term work, assisting governments with their responses to the pandemic. This has mitigated the effect of declines in established programs where our transaction volume has been reduced. We anticipate that our core programs will begin returning to capacity in the latter half of this year, as our COVID related work is expected to decline.
- As anticipated, the Census Questionnaire Assistance ("CQA") contract ended in the first quarter of fiscal year 2021.

### Results of Operations

*Table MD&A 1: Consolidated Results of Operations*

*(dollars in thousands, except per share data)*

|  | For the Three Months Ended December 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Revenue | $1,150,876 | $945,554 |
| Cost of revenue | 922,721 | 739,499 |
| Gross profit | 228,155 | 206,055 |
| **Gross profit percentage** | **19.8 %** | **21.8 %** |
| Selling, general, and administrative expenses | 124,221 | 111,967 |
| **Selling, general, and administrative expenses as a percentage of revenue** | **10.8 %** | **11.8 %** |
| Amortization of intangible assets | 22,405 | 6,516 |
| Operating income | 81,529 | 87,572 |
| **Operating income margin** | **7.1 %** | **9.3 %** |
| Interest expense | (9,638) | (206) |
| Other expense, net | (311) | (775) |
| Income before income taxes | 71,580 | 86,591 |
| Provision for income taxes | 18,250 | 22,514 |
| **Effective tax rate** | **25.5 %** | **26.0 %** |
| Net income | $53,330 | $64,077 |
| Earnings per share: |  |  |
| Basic | $0.86 | $1.03 |
| Diluted | $0.85 | $1.03 |

22

Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and related overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.

*Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended December 31, 2021*

*(dollars in thousands)*

|  | Revenue Dollars | % Change | Cost of Revenue Dollars | % Change | Gross Profit Dollars | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three Months Ended December 31, 2020 | $945,554 |  | $739,499 |  | $206,055 |  |
| Organic effect | (32,764) | (3.5)% | 10,844 | 1.5% | (43,608) | (21.2)% |
| Acquired growth | 235,766 | 24.9% | 170,187 | 23.0% | 65,579 | 31.8% |
| Currency effect compared to the prior period | 2,320 | 0.2% | 2,191 | 0.3% | 129 | 0.1% |
| Three Months Ended December 31, 2021 | $1,150,876 | 21.7% | $922,721 | 24.8% | $228,155 | 10.7% |

Selling, general, and administrative expenses ("SG&A") consists of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the U.S. Federal Government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards.

Our SG&A expense has increased year-over-year due primarily to the additional cost base from our acquisitions.

Our amortization of intangible assets increased by $15.9 million from three months ended December 31, 2020 to three months ended December 31, 2021.

- The intangible assets associated with the VES acquisition increased our amortization expense by $13.8 million.
- The intangible assets associated with the Attain acquisition increased our amortization expense by $2.6 million.
- The intangible assets associated with the Aidvantage acquisition increased our amortization expense by $1.7 million.
- Our acquisition of the Citizen Engagement Centers business in fiscal year 2019 included an intangible asset with a value of $37.0 million and an asset life concurrent with the CQA contract. This asset was fully amortized in November 2020, and this reduced our year-over-year charge by $2.3 million.
- The balance of the difference was derived from the Connect Assist acquisition and the effects of foreign currency translation.

*Table MD&A 3: Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets*

*(dollars in thousands, except per share data)*

|  | For the Three Months Ended December 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Operating income | $81,529 | $87,572 |
| Add back: Amortization of intangible assets | 22,405 | 6,516 |
| Adjusted operating income excluding amortization of intangible assets (Non-GAAP) | $103,934 | $94,088 |
| Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP) | 9.0% | 10.0% |
| Net income | $53,330 | $64,077 |
| Add back: Amortization of intangible assets, net of tax | 16,530 | 4,822 |
| Adjusted net income excluding amortization of intangible assets (Non-GAAP) | $69,860 | $68,899 |
| Diluted earnings per share | $0.85 | $1.03 |
| Add back: Effect of amortization of intangible assets on diluted earnings per share | 0.27 | 0.08 |
| Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP) | $1.12 | $1.11 |

Our intangible asset amortization is based upon our assumptions of the value and economic life, typically established at the acquisition date. If these assumptions change, the pattern of future expense may be accelerated. At this time, we have a significant asset related to a large contract relationship on a contract which is subject to a rebid in June 2022. If this rebid is unsuccessful, the asset life of this asset may need to be reduced.

Our interest expense increased from $0.2 million for the three months ended December 31, 2020 to $9.6 million for the same period in 2021. This increase is driven by the costs of our cash borrowings utilized to acquire VES. Interest expense is expected to be in the range of $33 million to $35 million for fiscal year 2022 due to the debt being outstanding for the entire fiscal year. Our interest rate will vary based upon both prevailing interest rates and our leverage ratio. Additional details on our borrowings are including within the "Liquidity and Capital Resources" section.

Our effective income tax rate for the three months ended December 31, 2021 and 2020, was 25.5% and 26.0%, respectively. For fiscal year 2022, we expect the effective tax rate to be between 25% and 26%.

### U.S. Services Segment

Our U.S. Services Segment provides a variety of business process services ("BPS") such as program administration, appeals and assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. Addressing societal macro trends such as aging populations and rising costs, the segment continues to execute on its clinical evolution strategy by expanding its clinical offerings in public health with new work in contact tracing, disease investigation, and vaccine distribution support services as part of the governments' COVID-19 response efforts. The segment also successfully expanded into the unemployment insurance market, supporting more than 15 states in their unemployment insurance programs.

*Table MD&A 4: U.S. Services Segment - Financial Results*

*(dollars in thousands)*

|  | For the Three Months Ended December 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Revenue | $386,417 | $384,934 |
| Cost of revenue | 296,718 | 285,932 |
| Gross profit | 89,699 | 99,002 |
| Selling, general, and administrative expenses | 35,102 | 37,456 |
| Operating income | 54,597 | 61,546 |
| Gross profit percentage | 23.2% | 25.7% |
| Operating margin percentage | 14.1% | 16.0% |

Our revenue and cost of revenue for the three months ended December 31, 2021, increased 0.4% and 3.8%, respectively, compared to the same period 2021. All growth was organic.

Many of our core programs continue to run at reduced capacity as a response to the COVID-19 pandemic. Among other factors, we are reporting lower volumes of transactions on redetermination activities as states have paused Medicaid redeterminations as a condition for receiving enhanced U.S. Federal matching funds. In certain cases, redeterminations provide a significant part of our activity within volume-based contracts. We are anticipating that redeterminations will commence in the latter half of this fiscal year but the timing and the nature of the change is uncertain.

In fiscal year 2021, we received a large volume of short term COVID-19 related work, typically at a higher margin. This work has declined in 2022, tempering those margins.

### U.S. Federal Services Segment

From technology solutions to program administration and operations, our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. Federal Government Agencies better deliver on their mission. This also includes appeals and assessments services, system and application development, IT modernization, and maintenance services. The segment also contains certain state-based assessments and appeals work that is part of the segment's heritage within the Medicare Appeals portfolio which continues to be managed within this segment. Benefiting from the Maximus Federal Consulting (formerly Attain Federal) platform, the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions with the acquisition of VES which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs. The segment further supports clinical offerings in public health with new work supporting the U.S. Federal Government's COVID-19 response efforts. This included expanded work with the Centers for Disease Control and Prevention ("CDC") for their helpline and increased support for the IRS Wage and Investment Division's response efforts to general inquiries regarding the Coronavirus Aid Relief & Economic Security ("CARES") Act and Economic Impact Payment Service Plan.

*Table MD&A 5: U.S. Federal Services Segment - Financial Results*

*(dollars in thousands)*

|  | For the Three Months Ended December 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Revenue | $581,871 | $405,245 |
| Cost of revenue | 455,295 | 322,749 |
| Gross profit | 126,576 | 82,496 |
| Selling, general, and administrative expenses | 64,925 | 52,252 |
| Operating income | 61,651 | 30,244 |
| Gross profit percentage | 21.8% | 20.4% |
| Operating margin percentage | 10.6% | 7.5% |

*Table MD&A 6: U.S. Federal Services Segment - Changes in Revenue, Cost of Revenue, and Gross Profit*

*(dollars in thousands)*

|  | Revenue Amount | % Change | Cost of Revenue Amount | % Change | Gross Profit Amount | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three Months Ended December 31, 2020 | $405,245 |  | $322,749 |  | $82,496 |  |
| Organic effect | (53,339) | (13.2)% | (34,064) | (10.6)% | (19,275) | (23.4)% |
| Acquired growth | 229,965 | 56.7% | 166,610 | 51.6% | 63,355 | 76.8% |
| Three Months Ended December 31, 2021 | $581,871 | 43.6% | $455,295 | 41.1% | $126,576 | 53.4% |

We received significant acquired growth from:

- VES, which we acquired in May 2021,
- Attain, which we acquired in March 2021, and
- The Aidvantage business, which we acquired in October 2021.

Our profit margins on VES and Attain are higher than our organic work, resulting in improvements to our profit margins. Our organic work tempered our margins. This was driven by a large contract we agreed to accept a lower margin in return for increased funding and future revenue.

In the first quarter of fiscal year 2021, we completed our work on the U.S. Census Questionnaire (CQA) contract, which did not recur in the first quarter of fiscal year 2022.

### Outside the U.S. Segment

Our Outside the U.S. Segment provides BPS for international governments and commercial clients, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker related services. We support programs and deliver services in the U.K., including the Health Assessment Advisory Service ("HAAS"), the Work & Health Programme, Fair Start, and Restart; Australia, including jobactive and the Disability Employment Service; Canada, including Health Insurance British Columbia and the Employment Program of British Columbia; in addition to Italy, Saudi Arabia, Singapore, South Korea, and Sweden, where we predominantly provide employment support and job seeker services.

*Table MD&A 7: Outside the U.S. Segment - Financial Results*

*(dollars in thousands)*

|  | For the Three Months Ended December 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Revenue | $182,588 | $155,375 |
| Cost of revenue | 170,708 | 130,818 |
| Gross profit | 11,880 | 24,557 |
| Selling, general, and administrative expenses | 21,340 | 20,032 |
| Operating (loss)/income | (9,460) | 4,525 |
| Gross profit percentage | 6.5% | 15.8% |
| Operating margin percentage | (5.2)% | 2.9% |

*Table MD&A 8: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit*

*(dollars in thousands)*

|  | Revenue Amount | % Change | Cost of Revenue Amount | % Change | Gross Profit Amount | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three Months Ended December 31, 2020 | $155,375 |  | $130,818 |  | $24,557 |  |
| Organic effect | 19,092 | 12.3% | 34,122 | 26.1% | (15,030) | (61.2)% |
| Acquired growth | 5,801 | 3.7% | 3,577 | 2.7% | 2,224 | 9.1% |
| Currency effect compared to the prior period | 2,320 | 1.5% | 2,191 | 1.7% | 129 | 0.5% |
| Three Months Ended December 31, 2021 | $182,588 | 17.5% | $170,708 | 30.5% | $11,880 | (51.6)% |

This segment experienced organic growth in revenue and costs, as well as acquired growth and currency benefits during the three months ended December 31, 2021.

Revenue growth was principally from our United Kingdom business, where the Restart contract continued to ramp up. Margins on the Restart contract are tempered as we have not yet reached our full service capacity. Elsewhere, our margins have contracted as caseload has declined; in the first quarter of fiscal year 2021, our margins were higher as we received the benefit from the recovery of our employment contracts in Australia.

Acquired growth is from the Connect Assist acquisition.

Much of our revenue, including that on the Restart contract, stems from our employment services contracts. On many contracts, we recognize revenue based upon estimates of future employment outcomes, which have become more volatile due to the effects of the COVID-19 pandemic, including those actions adopted by governments and employers. We update our estimates regularly based upon actual performance and updated expectations, but a sudden change in employment markets may result in significant fluctuations in our revenue.

### Liquidity and Capital Resources

Our primary sources of liquidity are cash on hand, cash flows from operating activities, and availability under our revolving credit facilities. As of December 31, 2021, we had $181.8 million in cash and cash equivalents. We believe that our current cash position, access to our revolvers, and cash flow generated from operations should be not only sufficient for our operating requirements but also to enable us to fund share repurchases and any required long-term debt payments through the next several fiscal years. See Note 7 to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.

*Table MD&A 10: Net Change in Cash and Cash Equivalents and Restricted Cash*

*(in thousands)*

| Operating activities: | For the Three Months Ended December 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Net income | $53,330 | $64,077 |
| Non-cash adjustments | 42,438 | 25,693 |
| Changes in working capital | (98,687) | 8,345 |
| Net cash (used in)/provided by operating activities | (2,919) | 98,115 |
| Net cash used in investing activities | (6,327) | (9,253) |
| Net cash provided by/(used in) financing activities | 54,916 | (31,487) |
| Effect of foreign exchange rates on cash and cash equivalents and restricted cash | 372 | 3,882 |
| Net change in cash and cash equivalents and restricted cash | $46,042 | $61,257 |

#### Net Cash (Used In)/Provided By Operating Activities

Net cash provided by operating activities decreased by $101.0 million for the three months ended December 31, 2021 compared to three months ended December 31, 2020. This decrease was primarily driven from a decrease in net income, increased working capital requirements, the timing of cash payments, including payments previously deferred in the United States under the CARES Act, and increased interest payments on our borrowings. Our Days Sales Outstanding ("DSO") as of both December 31, 2021 and September 30, 2021, were 67 days.

#### Net Cash Used In Investing Activities

The net cash used in investing activities were $6.3 million and $9.3 million for the three months ended December 31, 2021 and 2020, respectively. These cash outflows were primarily for capital expenditures to support our operations.

#### Net Cash Provided By/(Used In) Financing Activities

The $54.9 million cash provided by financing activities during the three months ended December 31, 2021, is primarily the result of a $100.0 million draw on our revolving credit line to fund operations, partially offset by $16.7 million of required debt payments on our term loans. Additionally, offsetting the cash flows related to debt, the Company also made $17.3 million in dividend payments, $9.7 million in tax payments for stock compensation, and $1.4 million for share repurchases. During the three months ended December 31, 2020, we had $31.5 million of cash used by financing activities, primarily being driven by dividend payments of $17.2 million, tax payments made related to stock compensation, and shares repurchases of $3.4 million.

With the acquisition of Aidvantage, we have incurred a liability to the seller based upon future performance, which we have estimated at $15.3 million. We expect these payments to be made through fiscal year 2024.

### Cash in Foreign Locations

We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.

### Free Cash Flow (Non-GAAP)

*Table MD&A 11: Free Cash Flow (Non-GAAP)*

*(in thousands)*

|  | For the Three Months Ended December 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Net cash (used in)/provided by operating activities | $(2,919) | $98,115 |
| Purchases of property and equipment and capitalized software | (6,327) | (9,094) |
| Free cash flow (Non-GAAP) | $(9,246) | $89,021 |

### Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2021 Form 10-K, as filed with the SEC on November 18, 2021, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the three months ended December 31, 2021.

### Non-GAAP and Other Measures

We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operating activities, net income, or earnings per share as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

In fiscal year 2021, 16% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology which excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal year's results for all foreign businesses using the exchange rates in the prior fiscal year. We refer to this adjusted revenue on a "constant currency basis."

In recent years, we have made a number of acquisitions. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal year results excluding transactions from acquisitions or disposals to our prior fiscal year results.

Our recent acquisitions have resulted in significant intangible assets which are amortized over their estimated useful lives. We believe users of our financial statements wish to understand the performance of the business by using a methodology that allows them to compare operating activities excluding the effects of the amortization of intangible assets. Accordingly, we have calculated our operating profit, net income, and earnings per share excluding the effect of the amortization of intangible assets. We have included a table showing our reconciliation of these income measures to their corresponding GAAP measures.

In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology which combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of the Company's operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operating activities to free cash flow in "Liquidity and Capital Resources."

To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.

As noted above, we have a $2.10 billion corporate credit facility. Our credit agreement includes the defined term Consolidated EBITDA and our calculation of Adjusted EBITDA conforms to the credit agreement definition. We believe our investors appreciate the opportunity to understand the possible restrictions which arise from our credit agreement.

- Adjusted EBITDA is also a useful measure of performance which focuses on the cash generating capacity of the business as it excludes the non-cash expenses of depreciation and amortization, and makes for easier comparisons between the operating performance of companies with different capital structures by excluding interest expense and therefore the impacts of financing costs.
- The measure of Adjusted EBITA is a step in calculating Adjusted EBITDA and facilitates comparisons to similar businesses as it isolates the amortization effect of business combinations.
- Our corporate credit facility requires us to calculate Adjusted EBITDA on a pro forma basis, as though we had owned any significant acquired business for a full twelve months. Accordingly, we have included the effects of VES, Attain, Aidvantage, and Connect Assist in the table below.

We have provided a reconciliation from net income to Non-GAAP Adjusted EBITA, Non-GAAP Adjusted EBITDA, and Non-GAAP Pro Forma Adjusted EBITDA as shown below. Our current credit facilities utilized a different version of EBITDA from that of the credit facility used in prior years.

*Table MD&A 12: Reconciliation of Net Income to Non-GAAP Adjusted EBITA, Non-GAAP Adjusted EBITDA, and Non-GAAP Pro Forma Adjusted EBITDA*

*(in thousands)*

|  | For the Three Months Ended December 31, 2021 | For the Trailing Twelve Months Ended December 31, 2021 |
| --- | ---: | ---: |
| Net income | $53,330 | $280,453 |
| Adjustments: |  |  |
| Interest expense | 9,638 | 24,176 |
| Other expense, net | 311 | 9,641 |
| Provision for income taxes | 18,250 | 88,216 |
| Amortization of intangibles | 22,405 | 60,247 |
| Stock compensation expense | 8,248 | 30,741 |
| Acquisition-related expenses | 2,490 | 12,661 |
| Adjusted EBITA - Non-GAAP measure | 114,672 | 506,135 |
| Depreciation and amortization of property, equipment, and capitalized software | 11,365 | 45,909 |
| Adjusted EBITDA - Non-GAAP measure | $126,037 | $552,044 |
| Pro forma adjusted EBITDA related to acquisitions - Non-GAAP measure |  | 75,031 |
| Pro forma adjusted EBITDA - Non-GAAP measure |  | $627,075 |

30

## Market risk

As filed, 517 characters.

In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on the 2021 Form 10-K, as filed with the SEC on November 18, 2021, have not changed materially during the three month period ended December 31, 2021.

## Controls and procedures

As filed, 1,806 characters.

Management's Evaluation of Disclosure Controls and Procedures. The Company maintains disclosure controls and procedures designed to ensure that information required to be disclosed in its periodic filings under the Securities Exchange Act of 1934 ("Exchange Act"), including this Quarterly Report on Form 10-Q, is recorded, processed, summarized, and reported on a timely basis. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to the Company's management on a timely basis to allow decisions about required disclosure. Management, including the Company's Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of Maximus' disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of December 31, 2021.

Maximus carried out the evaluation of the effectiveness of its disclosure controls and procedures, required by paragraph (b) of Exchange Act Rules 13a-15 and 15d-15, under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective as of December 31, 2021.

Changes in Internal Control Over Financial Reporting. There were no changes in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) during the three months ended December 31, 2021, that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

## Risk factors

As filed, 186 characters.

There were no material changes during the three months ended December 31, 2021 to the risk factors previously disclosed in the 2021 Form 10-K, as filed with the SEC on November 18, 2021.

Filed Feb 3, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-001760. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
